Tumor-derived ANGPTL4 interacts with integrins to regulate cancer progression by triggering the PI3K-associated signaling [49] and partly due to suppression of ERK signaling [46], which is also consistent with our findings as we have shown that integrin signaling pathway involving ERK and PI3K are regulated by ANGPTL4. The gene discussed is ANGPTL4; the disease is cancer.